Cephalic Version by Acupuncture for Breech Presntation

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT00813683
First received: December 22, 2008
Last updated: June 17, 2014
Last verified: December 2008

December 22, 2008
June 17, 2014
February 2008
May 2014   (final data collection date for primary outcome measure)
Cephalic or breech presentation (ultrasonographic control at 35 weeks of pregnancy) [ Time Frame: 35 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00813683 on ClinicalTrials.gov Archive Site
Increase of fetal movements [ Time Frame: 35 weeks ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Cephalic Version by Acupuncture for Breech Presntation
Study of Cephalic Version by Acupuncture for Breech Presntation.

We want to study the efficiency of acupuncture for cephalic version of breech presentation during pregnancy.

Several randomized studies show that acupuncture may be useful in version of breech presentation, but none with a placebo.

Protocol :

  • Inclusion of patients with fetus in breech presentation at 32-33 weeks of pregnancy.
  • Randomization. First group : acupuncture by stimulation of "67 Bladder" point.Second group : stimulation of "45 Stomach" point (placebo).
  • Ultrasonographic control of presentation at 35 weeks.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Breech Presentation
  • Other: Acupuncture stimulation
    Acupuncture by stimulation of "67 Bladder" point
  • Other: Acupuncture stimulation
    Acupuncture stimulation of "45 Stomach" point (placebo)
  • Experimental: 1
    Stimulation of "67 Bladder" point
    Intervention: Other: Acupuncture stimulation
  • Placebo Comparator: 2
    Stimulation of "45 Stomach" point (placebo)
    Intervention: Other: Acupuncture stimulation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
259
May 2014
May 2014   (final data collection date for primary outcome measure)

Inclusion criteria:

  • Single pregnancy at 32-34 weeks of pregnancy.
  • Fetus in breech presentation.

Exclusion criteria:

  • Twins.
  • Story of preterm birth or any preterm birth risk
  • Fetal malformations, abnormal karyotype
Female
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00813683
3993
No
Emmanuel LAVOUE, Directeur Adjoint, University Hospital, Strasbourg, France
University Hospital, Strasbourg, France
Not Provided
Principal Investigator: Romain FAVRE, MD Hôpitaux Universitaires de Strasbourg
University Hospital, Strasbourg, France
December 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP